Giuliani N - Search Results

1

Telomere dysfunction drives aberrant hematopoietic differentiation and myelodysplastic syndrome.

Colla S, Ong DS, Ogoti Y, Marchesini M, Mistry NA, Clise-Dwyer K, Ang SA, Storti P, Viale A, Giuliani N, Ruisaard K, Ganan Gomez I, Bristow CA, Estecio M, Weksberg DC, Ho YW, Hu B, Genovese G, Pettazzoni P, Multani AS, Jiang S, Hua S, Ryan MC, Carugo A, Nezi L, Wei Y, Yang H, D'Anca M, Zhang L, Gaddis S, Gong T, Horner JW, Heffernan TP, Jones P, Cooper LJ, Liang H, Kantarjian H, Wang YA, Chin L, Bueso-Ramos C, Garcia-Manero G, DePinho RA. Colla S, et al. Among authors: giuliani n. Cancer Cell. 2015 May 11;27(5):644-57. doi: 10.1016/j.ccell.2015.04.007. Cancer Cell. 2015. PMID: 25965571 Free PMC article.

2

Angiopoietins expression by human myeloma cells.

Colla S, Roti G, Rizzoli V, Giuliani N. Colla S, et al. Among authors: giuliani n. Haematologica. 2003 Jun;88(6):ELT20; author reply ELT21. Haematologica. 2003. PMID: 12801859 No abstract available.

3

Do human myeloma cells directly produce the receptor activator of nuclear factor kappaB ligand (RANKL) or induce RANKL in the bone marrow microenvironment?

Giuliani N, Colla S, Rizzoli V, Barillé-Nion S, Bataille R. Giuliani N, et al. Cancer Res. 2004 Jan 15;64(2):772-3; author reply 774-5. Cancer Res. 2004. PMID: 14744797 No abstract available.

4

New insight in the mechanism of osteoclast activation and formation in multiple myeloma: focus on the receptor activator of NF-kappaB ligand (RANKL).

Giuliani N, Colla S, Rizzoli V. Giuliani N, et al. Exp Hematol. 2004 Aug;32(8):685-91. doi: 10.1016/j.exphem.2004.03.015. Exp Hematol. 2004. PMID: 15308315 Free article. Review.

5

The RANK/RANK ligand system is involved in interleukin-6 and interleukin-11 up-regulation by human myeloma cells in the bone marrow microenvironment.

Giuliani N, Colla S, Morandi F, Rizzoli V. Giuliani N, et al. Haematologica. 2004 Sep;89(9):1118-23. Haematologica. 2004. PMID: 15377473

6

Angiopoietin-1 and myeloma-induced angiogenesis.

Giuliani N, Colla S, Morandi F, Rizzoli V. Giuliani N, et al. Leuk Lymphoma. 2005 Jan;46(1):29-33. doi: 10.1080/1042-8190400001022. Leuk Lymphoma. 2005. PMID: 15621778 Review.

7

Angiogenic switch in multiple myeloma.

Giuliani N, Colla S, Rizzoli V. Giuliani N, et al. Hematology. 2004 Oct-Dec;9(5-6):377-81. doi: 10.1080/10245330400018524. Hematology. 2004. PMID: 15763977 Free article. Review.

8

Update on the pathogenesis of osteolysis in multiple myeloma patients.

Giuliani N, Colla S, Rizzoli V. Giuliani N, et al. Acta Biomed. 2004 Dec;75(3):143-52. Acta Biomed. 2004. PMID: 15796087 Review.

9

CC-chemokine ligand 20/macrophage inflammatory protein-3α and CC-chemokine receptor 6 are overexpressed in myeloma microenvironment related to osteolytic bone lesions.

Giuliani N, Lisignoli G, Colla S, Lazzaretti M, Storti P, Mancini C, Bonomini S, Manferdini C, Codeluppi K, Facchini A, Rizzoli V. Giuliani N, et al. Cancer Res. 2008 Aug 15;68(16):6840-50. doi: 10.1158/0008-5472.CAN-08-0402. Cancer Res. 2008. PMID: 18703490

10

Interleukin-27 acts as multifunctional antitumor agent in multiple myeloma.

Cocco C, Giuliani N, Di Carlo E, Ognio E, Storti P, Abeltino M, Sorrentino C, Ponzoni M, Ribatti D, Airoldi I. Cocco C, et al. Among authors: giuliani n. Clin Cancer Res. 2010 Aug 15;16(16):4188-97. doi: 10.1158/1078-0432.CCR-10-0173. Epub 2010 Jun 29. Clin Cancer Res. 2010. PMID: 20587591

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

245 results

Search Page

Filters